Capricor Therapeutics
CAPR
#4848
Rank
A$2.67 B
Marketcap
A$46.47
Share price
6.61%
Change (1 day)
201.69%
Change (1 year)

Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Volume in USD (price x number of shares), data since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026A$1.81 M-98.85%
2025A$0.15 B154.62%
2024A$61.89 M1584.06%
2023A$3.67 M24.67%
2022A$2.94 M-49.93%
2021A$5.88 M-88.57%
2020A$51.49 M573.14%
2019A$7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
A$55.5 MA$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$4.15 MA$27.32 M๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
A$14.08 MA$39.43 M๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$1.57 MA$11.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A$0.52 MA$1.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/AA$0.06 M๐Ÿ‡บ๐Ÿ‡ธ USA